Financials

  • Market Capitalization 8.58 M
  • Employee 8
  • Founded 2011
  • CEO Paul Kang
  • Website www.exicuretx.com
  • Headquarter Delaware, United States
  • FIGI BBG00GTJCSB4
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-6.86
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4803
IMNN
Imunon, Inc. - Common Stock
1.59 USD-0.63%-2.45%+6.00%-51.08%8.92 M USD
4804
TRAW
Traws Pharma, Inc. - Common Stock
0.58 USD-1.69%+9.43%+16.00%-59.15%8.91 M USD
4812
CNSP
CNS Pharmaceuticals, Inc. - Common Stock
5.52 USD0.00%-3.16%+10.40%-12.38%8.07 M USD
4816
SNGX
Soligenix, Inc. - Common Stock
0.38 USD0.00%-2.56%+5.56%-66.37%8.27 M USD

Notizie